Evaluation of the DQIP measures in nine managed care plans with Medicare participation
| Measure | Mean | Maximum | Minimum |
|---|---|---|---|
| HbA1c testing (annual) | 72 | 93 | 50 |
| HbA1c ≥9.5% | 35 | 55 | 12 |
| Lipid testing (biennial) | 62 | 74 | 47 |
| LDL <130 mg/dl | 38 | 49 | 22 |
| Blood pressure controlled (based on last value) | 37 | 47 | 31 |
| Foot examination (annual) | 42 | 61 | 16 |
| Eye examination (biennial for low-risk*, otherwise annual) | 41 | 72 | 8 |
| Nephropathy monitored† | 34 | 63 | 22 |
Data are %. Denominators for all measures were Medicare beneficiaries aged 18–75 years identified with diabetes using a validated algorithm based on ICD-9 codes or selected from pharmacy records based on use of insulin or oral agents for treating diabetes. Percentages shown reflect the proportion of patients receiving the test or achieving the result specified. All plans had ≥100 records.
↵* Low-risk patients had two of the following: no retinopathy in the examination before the reporting year, not taking insulin, or an HbA1c level of ≤8%.
↵† Low-risk patients had two of the following: no microalbuminuria on testing in the year before the reporting year, not taking insulin, or an HbA1c level of ≤8%.